Effect of renal impairment on the pharmacokinetics of exenatide.

Authors:
Linnebjerg H; Kothare PA; Park S; Mace K; Reddy S and 2 more

Journal:
Br J Clin Pharmacol

Publication Year: 2007

DOI:
10.1111/j.1365-2125.2007.02890.x

PMCID:
PMC2000650

PMID:
17425627

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Br J Clin Pharmacol

Abbreviation: Br J Clin Pharmacol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamic results of KCL-286, a novel reti…
Goncalves MB; Mant T; Täubel J and 8 more (2023) - Transparency Score: 4/6
A comprehensive pharmacogenomic study indicates roles for SLCO1B1, ABCG2 and SLCO2B1 in rosuvastati…
Lehtisalo M; Taskinen S; Tarkiainen EK and 8 more (2022) - Transparency Score: 3/6
A crossover study evaluating the sex-dependent and sensitizing effects of sleep deprivation using a…
Hijma H; Koopmans I; Klaassen E and 3 more (2022) - Transparency Score: 4/6
Acute response to cholinergic challenge predicts long-term response to galantamine treatment in pat…
Baakman AC; Gavan C; van Doeselaar L and 12 more (2022) - Transparency Score: 4/6
An e-Delphi study to obtain expert consensus on the level of risk associated with preventable e-pre…
Heed J; Klein S; Slee A and 3 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests This work was sponsored by Eli Lilly and Co. and Amylin Pharmaceuticals, Inc. and is related to study protocols H8O-EW-GWAB, 2993-102, 2993-103, 2993-110 and 2993-118. The authors thank Dr Jacques Bagon, Dr Annemie Knops and Dr Patricia van der Niepen for conducting the clinical evaluations, Michael Kallin Carter for technical assistance in statistical evaluation of data, David Webb PhD and Dr Jie Mao for assistance in preparing the manuscript, and Eric Vandeloise for monitoring the study sites."

Evidence found in paper:

"This work was sponsored by Eli Lilly and Co. and Amylin Pharmaceuticals, Inc. and is related to study protocols H8O-EW-GWAB, 2993-102, 2993-103, 2993-110 and 2993-118."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025